USPTO serial 76677125
ENDOTAG
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- VERHOSEK, WILLIAM T
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENDOTAG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
82152 Planegg/Martinsried, DE
82152 Planegg/Martinsried, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Adrienne L. White
Adrienne L. White WRB-IP LLPP.O. Box 476Wadsworth, OH 44282UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 10, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 10, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 8, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 7, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 2, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 2, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 7, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 2, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 29, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 14, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 12, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 5, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 30, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 29, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 28, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 28, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 10, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 18, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 13, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 28, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 26, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 26, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 17, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2008 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2007 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 1, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2007 | NWAP | NEW APPLICATION ENTERED | — |